Showing results (21-30 of 91) with videos related to

Sort By:
Pageof 10
Scientific Reports|April 9, 2022
Development and validation of a predictive nomogram for preoperative deep vein thrombosis (DVT) in isolated calcaneal fractureXinqun Cheng, Xiang Lei, Haifeng Wu, et al.
Mitochondrial DNA. Part A, DNA Mapping, Sequencing, and Analysis|August 5, 2014
Development of deft amplification refractory mutation sequencing system (ARMSS) for discriminating Pilos antler based on a short cytochrome b (Cytb) geneXueyong Wang, Guojie Xu, Chunsheng Liu, et al.
Frontiers in Cellular and Infection Microbiology|February 23, 2017
Heparin-binding Hemagglutinin of <i>Mycobacterium tuberculosis</i> Is an Inhibitor of AutophagyQing Zheng, Zhi Li, Shan Zhou, et al.
Frontiers in Immunology|August 29, 2022
Strategies to overcome CAR-T cell resistance in clinical work: A single-institute experienceFeifei Nan, Xiaorui Fu, Xinfeng Chen, et al.
Cancer Management and Research|April 25, 2019
Clinical features and prognostic factors of primary bone marrow lymphomaGangjian Wang, Yu Chang, Xiaolong Wu, et al.
Investigational New Drugs|May 5, 2020
Apatinib, a novel VEGFR-2 tyrosine kinase inhibitor, for relapsed and refractory nasopharyngeal carcinoma: data from an open-label, single-arm, exploratory studyLing Li, Fei Kong, Lei Zhang, et al.
Biochemical and Biophysical Research Communications|September 12, 2018
Platelet-derived growth factor receptor alpha (PDGFRα) is overexpressed in NK/T-cell lymphoma and mediates cell survivalLisha Lu, Xiaorui Fu, Zhaoming Li, et al.
Biomedical Chromatography : BMC|September 22, 2015
LC-MS based metabolomics identification of novel biomarkers of tobacco smoke-induced chronic bronchitisXiaolei Ren, Jiayu Zhang, Xiaorui Fu, et al.
Frontiers in Cellular and Infection Microbiology|September 27, 2021
Characteristics and Clinical Implications of the Nasal Microbiota in Extranodal NK/T-Cell Lymphoma, Nasal TypeZhuangzhuang Shi, Xin Li, Xinhua Wang, et al.
Annals of Hematology|April 26, 2021
Ibrutinib combined with venetoclax for the treatment of relapsed/refractory diffuse large B cell lymphomaZhiyuan Zhou, Lei Zhang, Xinhua Wang, et al.
Pageof 10